Hongqiang Qiu

Dr. Hongqiang Qiu

Fujian Medical University Union Hospital, Fuzhou, Fujian, China
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
HLHailing Lin
Hailing Lin
HQHongqiang Qiu
Hongqiang Qiu
YCYu Cheng
Yu Cheng
MLMaobai Liu
Maobai Liu
MCMaohua Chen
Maohua Chen
WQWancai Que
Wancai Que
Gelsemium elegans Benth (GEB), also known as heartbreak grass, is a highly poisonous plant belonging to the family Loganiaceae and genus Gelsemium that has broad application prospects in medicine. This article reviews its chemical components, pharmacological effects, toxicity mechanisms, and research progress in clinical applications in recent years. Indole alkaloids are the main active components of GEB and have a variety of pharmacological and biological functions. They have anti-tumor, anti-inflammatory, analgesic, and immunomodulation properties, with the therapeutic dose being close to the toxic dose. Application of small-dose indole alkaloids fails to work effectively, while high-dose usage is prone to poisoning, aggravating the patient’s conditions. Special caution is needed, especially to observe the changes in the disease condition of the patients in clinical practice. In-depth research on the chemical components and mechanisms of GEB is essential to the development of promising lead compounds and lays the foundation for extensive clinical application and safe usage of GEB in the future.

20 March 2021 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
WQWancai Que
Wancai Que
MCMaohua Chen
Maohua Chen
LYLing Yang
Ling Yang
BZBingqing Zhang
Bingqing Zhang
ZZZhichang Zhao
Zhichang Zhao
HQHongqiang Qiu
Hongqiang Qiu
Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related death worldwide.Gelsemium elegans Benth(GEB) is a traditional Chinese medicine commonly used for treatment for gastrointestinal cancer, including CRC. However, the underlying active ingredients and mechanism remain unknown. This study aims to explore the active components and the functional mechanisms of GEB in treating CRC by network pharmacology-based approaches.Methods: Candidate compounds of GEB were collected from the Traditional Chinese Medicine@Taiwan, Traditional Chinese Medicines Integrated Database, Bioinformatics Analysis Tool for Molecular mechanism of Traditional Chinese Medicine, and published literature. Potentially active targets of compounds in GEB were retrieved from SwissTargetPrediction databases. Keywords “colorectal cancer”, “rectal cancer” and “colon cancer” were used as keywords to search for related targets of CRC from the GeneCards database, then the overlapped targets of compounds and CRC were further intersected with CRC related genes from the TCGA database. The Cytoscape was applied to construct a graph of visualized compound-target and pathway networks. Protein-protein interaction networks were constructed by using STRING database. The DAVID tool was applied to carry out Gene Ontology and Kyoto Encyclopedia of Genes and Genome pathway enrichment analysis of final targets. Molecular docking was employed to validate the interaction between compounds and targets. AutoDockTools was used to construct docking grid box for each target. Docking and molecular dynamics simulation were performed by Autodock Vina and Gromacs software, respectively.Results: Fifty-three bioactive compounds were successfully identified, corresponding to 136 targets that were screened out for the treatment of CRC. Functional enrichment analysis suggested that GEB exerted its pharmacological effects against CRC via modulating multiple pathways, such as pathways in cancer, cell cycle, and colorectal cancer. Molecular docking analysis showed that the representative compounds had good affinity with the key targets. Molecular dynamics simulation indicated that the best hit molecules formed a stable protein-ligand complex.Conclusion: This network pharmacology study revealed the multiple ingredients, targets, and pathways synergistically involved in the anti-CRC effect of GEB, which will enhance our understanding of the potential molecular mechanism of GEB in treatment for CRC and lay a foundation for further experimental research.

26 January 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
YCYu Cheng
Yu Cheng
MCMao‐Hua Chen
Mao‐Hua Chen
QZQian Zhuang
Qian Zhuang
BLBi‐Juan Lin
Bi‐Juan Lin
YCYing‐Ying Chen
Ying‐Ying Chen
HQHongqiang Qiu
Hongqiang Qiu

1 August 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XZXiaofang Zeng
Xiaofang Zeng
HCHongfu Cai
Hongfu Cai
JYJing Yang
Jing Yang
HQHongqiang Qiu
Hongqiang Qiu
YCYu Cheng
Yu Cheng
MLMaobai Liu
Maobai Liu
Doxorubicin (DOX) is an effective chemotherapeutic drug. However, its clinical application may be hampered by dose-dependent cardiotoxicity. Alcohol metabolite and doxorubicinol (DOXol) were the most prominent components in DOX-induced cardiotoxicity. It is necessary to elucidate the level of DOXol in heart in vivo and whether DOXol could cause toxicity at such a concentration. The pharmacokinetics and heart distribution of DOX and its second metabolite DOXol were determined in rats. Based on this concentration level in vivo, H9C2 cell was used to examine the cardiotoxicity of DOX and DOXol. Real-time cell viability was determined using the xCelligence system and the membrane-permeable of DOX, and DOXol was also assessed by determining the intracellular and extracellular concentrations. Our data showed that DOX level was higher than DOXol level in heart tissue. DOX had a high level in intracellular H9C2 cell and was the primary cytotoxic agent. DOXol had a significantly low level in heart tissue and less cytotoxicity than that of DOX in H9C2. DOXol in heart could not diffuse from plasma but only form in the heart. DOXol could not enter cell as easy as DOX. The less cardiotoxicity of DOXol might be caused by the less intracellular concentration.

1 January 2015 in Molecular Pain
Verified
Journal Article
Open access
HQHongqiang Qiu
Hongqiang Qiu
YXYing Xu
Ying Xu
GJGui-Lin Jin
Gui-Lin Jin
JYJian Yang
Jian Yang
MLMing Liu
Ming Liu
CYChang-Xi Yu
Chang-Xi Yu
Background: Koumine is an alkaloid monomer found abundantly in Gelsemium plants. It has been shown to reverse thermal hyperalgesia and mechanical allodynia induced by sciatic nerve chronic constriction injury (CCI) in rats in a dose-dependent manner. Interestingly, this effect is mediated by elevated allopregnanolone levels in the spinal cord (SC). Since 3α-hydroxysteroid oxidoreductase (3α-HSOR), the key synthetase of allopregnanolone, is responsible for allopregnanolone upregulation in the SC, the objective of the present study was to investigate the role of its expression in the SC in koumine-induced analgesia using a rat model of neuropathic pain following peripheral nerve injury.Results: Time-course investigations of immunohistochemistry and real-time polymerase chain reaction revealed that the immunoreactivity and mRNA expression of 3α-HSOR markedly increased in a time-dependent manner in the SC of koumine-treated CCI rats. Furthermore, 3α-HSOR activity in the SC of koumine-treated CCI rats increased by 15.8% compared to the activity in untreated CCI rats. Intrathecal injection of medroxyprogesterone acetate, a selective 3α-HSOR inhibitor, reversed the analgesic effect of koumine on CCI-induced mechanical pain perception. Our results confirm that koumine alleviates neuropathic pain in rats with CCI by enhancing 3α-HSOR mRNA expression and bioactivity in the SC.Conclusion: This study demonstrates that 3α-HSOR is an important molecular target of koumine for alleviating neuropathic pain. Koumine may prove a promising compound for the development of novel analgesic agents effective against intractable neuropathic pain.

13 February 2023 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
BZBingqing Zhang
Bingqing Zhang
XLXueyong Li
Xueyong Li
YCYiying Chen
Yiying Chen
BCBo Chen
Bo Chen
YCYu Cheng
Yu Cheng
CWChaoyang Wu
Chaoyang Wu